Northwest Investment Counselors’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$59.4K Buy
+121
New +$56.3K 0.01% 229
2024
Q2
Sell
-48
Closed -$19.2K 326
2024
Q1
$19.2K Buy
+48
New +$18.1K ﹤0.01% 314
2023
Q4
Sell
-36
Closed -$10.5K 330
2023
Q3
$10.5K Hold
36
﹤0.01% 379
2023
Q2
$12.3K Hold
36
﹤0.01% 371
2023
Q1
$9.2K Hold
36
﹤0.01% 406
2022
Q4
$9.55K Sell
36
-7
-16% -$1.71K ﹤0.01% 407
2022
Q3
$8K Hold
43
﹤0.01% 392
2022
Q2
$9K Hold
43
﹤0.01% 374
2022
Q1
$13K Buy
43
+7
+19% +$2.04K ﹤0.01% 361
2021
Q4
$13K Buy
+36
New +$12.4K ﹤0.01% 342
2021
Q2
Sell
-36
Closed -$9K 288
2021
Q1
$9K Buy
+36
New +$9.06K ﹤0.01% 373
2020
Q4
Sell
-36
Closed -$9K 284
2020
Q3
$9K Buy
+36
New +$8.08K ﹤0.01% 334
2019
Q4
Sell
-36
Closed -$6K 329
2019
Q3
$6K Buy
+36
New +$6.23K ﹤0.01% 412

Other funds holding ISRG

Northwest Investment Counselors's ISRG Position: Q3 2024 in Review

Northwest Investment Counselors opened a new position in Intuitive Surgical (ISRG) in Q3 2024: 121 shares worth $59.4K. The stake represents 0.01% of the portfolio and ranks #229 among its holdings. This is a return to the name: Northwest Investment Counselors previously reported a position in ISRG as recently as Q1 2024.

Northwest Investment Counselors first reported a position in ISRG in Q3 2019 and has held it in 13 quarters since. 1,951 funds tracked by Wall St. Rank hold ISRG as of Q3 2024.

  • Northwest Investment Counselors held 121 shares of Intuitive Surgical worth $59.4K as of Q3 2024.
  • Intuitive Surgical was a new Northwest Investment Counselors position in Q3 2024.
  • Intuitive Surgical made up 0.01% of Northwest Investment Counselors's portfolio in Q3 2024, its #229 holding.
  • Northwest Investment Counselors first reported a position in Intuitive Surgical in Q3 2019 and has held it in 13 quarters since.
  • 1,951 funds tracked by Wall St. Rank held Intuitive Surgical as of Q3 2024.

Based on Northwest Investment Counselors's 13F filing for Q3 2024, filed 21 Oct 2024.